<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02151266</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00060752</org_study_id>
    <secondary_id>P30NR014134</secondary_id>
    <nct_id>NCT02151266</nct_id>
  </id_info>
  <brief_title>Exercise and Cognitive Retraining to Improve Cognition in Heart Failure.</brief_title>
  <acronym>EXCITE</acronym>
  <official_title>The Feasibility of Exercise and Cognitive Retraining to Improve Memory, Attention and Concentration in Heart Failure.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Nursing Research (NINR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Emory University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cognitive impairment (CI) is a prevalent problem in persons with HF heart failure (HF) and is
      associated with adverse clinical outcomes, higher mortality and poorer quality of life.
      Studies designed to attenuate or alleviate CI in persons with HF are limited, and evidenced
      based guidelines for screening and provision of care are practically nonexistent. Improvement
      in cognition has been reported following some therapies in HF and is thought to be the
      consequence of enhanced cerebral perfusion and oxygenation, suggesting that CI may be
      amenable to intervention in this population. Exercise is documented to increase cerebral
      perfusion and oxygenation by promoting neuroplasticity and neurogenesis, and, in turn,
      cognitive functioning. Brain derived neurotrophic factor (BDNF) is a key mechanism underlying
      the effect of exercise, but most studies of BDNF have not included individuals with CI or
      chronic illness populations, and its relationship to cognitive outcomes in HF is unknown.
      Cognitive retraining techniques, originally developed to treat traumatic brain injury, have
      also shown efficacy in broader neurologically-affected conditions and may provide added
      benefit to that of exercise. Animal studies suggest exercise and plasticity-based cognitive
      training could act synergistically through different neural mechanisms to have a more
      pronounced and positive impact on cognitive outcomes than either approach alone; but this has
      not been previously tested as an intervention to improve CI. The proposed feasibility study
      is designed to test the acceptability and limited efficacy of a combined exercise (Ex) and
      cognitive training (CT) program to improve CI in stable NYHA class II and III HF patients
      compared to either exercise alone or a no-intervention, attention-control group. Findings
      will be used to support the development of a future, large scale study to test the efficacy
      of this intervention to improve cognitive functioning, quality of life, and physiological
      markers of improved brain function in HF. In addition, we have an optional sub-study that
      participants may participate in order to further our understanding of biomarkers of
      inflammation and gen e expression before and after exercise.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Persons with heart failure (HF) have a four-fold greater likelihood of developing cognitive
      impairment (CI) than their age matched healthy counterparts, placing them at high risk for
      adverse clinical outcomes, poorer quality of life (QOL) and higher mortality. CI is a subtle
      but measurable deficit in one or multiple cognitive domains; it is a deficit greater than
      cognitive losses associated with normal aging. The few studies that have documented CI in HF
      are inconsistent. Few have used standard neuropsychological testing, and little is known
      about change in cognitive function over time in HF. Further, if CI is detected, there are
      currently no effective or evidenced-based guidelines to help restore or improve cognition in
      this population.Despite the aging population and projected rise of CI in HF, only 2 small
      intervention studies have been documented, indicating a critical need for further research in
      this area.

      The etiology of CI in HF is not fully understood, but several underlying mechanisms are
      consistently reported: reduced cerebral perfusion and oxygenation, brain structural changes
      (i.e., hippocampal damage, atrophy, loss of gray matter), and micro emboli.Clinical studies
      have shown that CI is improved after cardiac transplantation and is modifiable with standard
      therapies that improve cardiac output, oxygenation, fluid overload, and systemic and cerebral
      perfusion; these findings are inconsistent and anecdotal. The ability to positively influence
      cognitive function has important implications for patient adherence to a complex self-care
      regimen and the development of interventions that may partially reverse CI.

      Exercise improves clinical outcomes in HF by altering the deleterious peripheral and central
      mechanisms that contribute to HF exacerbations, worsen symptom severity, and lead to poor
      clinical outcomes. Less is known about the effect of exercise on cognitive function. Animal
      research has provided the most compelling evidence that exercise positively affects neuronal
      growth and the neural systems involved in learning and memory. Similar human findings have
      emerged; recent advances in neuroimaging support that participation in regular exercise leads
      to specific changes in brain structure and function. Exercise is also thought to enhance
      brain plasticity. BDNF appears to play a crucial role in this process: when BDNF levels
      increase following exercise, cognitive function improves. The association between exercise,
      BDNF and cognitive function has not been previously reported in HF. This feasibility study
      will clarify these important relationships and increase the potential for improving clinical
      outcomes in a future trial.

      Neurogenesis and neuroplasticity are means for the brain to recover from poor perfusion and
      oxygen deprivation such as that occurring in HF. Animal studies again provide the strongest
      evidence to date for using cognitive training (CT) to promote better cognitive functioning
      and provide a rationale for why a combined exercise and CT approach may be superior to
      monotherapy. Animal studies show that, like exercise, learning tasks and performing
      cognitively stimulating activities also increase BDNF levels and improve learning and memory.
      The effect of BDNF on brain function due to exercise however, is thought to be different from
      that occurring with CT. Exercise increases the proliferation and division of neuronal cells
      through BDNF, whereas CT appears to promote cell survival,suggesting a synergistic
      relationship may exist with greater benefit obtained when both are used together. The
      combination of exercise and plasticity-based CT has not been previously tested in HF or in
      other populations as an intervention for improving cognitive outcomes, but may be most
      optimal for targeting the underlying mechanisms for CI in HF. The proposed feasibility study
      is designed to test the acceptability, implementation and limited efficacy of a combined
      exercise (Ex) and cognitive training (CT) intervention in stable NYHA class II and III heart
      failure patients with cognitive impairment. A total of 60 participants will be randomized to
      one of three study arms: Ex/CT (N=20), Ex-alone (N=20), and attention control (N=20). The
      study aims are:

      Aim 1: To evaluate the feasibility of a 3-arm intervention (ExCT, Ex, AC) in heart failure
      patients with CI.

      Aim 1a. To test the acceptability and implementation of each study arm. Aim 2: To ascertain
      limited efficacy of the 3-arm intervention on changes in cognitive abilities Aim 3: To
      ascertain limited efficacy of the 3-arm intervention to improve cerebral oxygenation,
      physiological status, physical function and QOL.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">December 30, 2017</completion_date>
  <primary_completion_date type="Actual">December 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Verbal Memory Score Change</measure>
    <time_frame>Baseline, 3 months, 6 months</time_frame>
    <description>List Learning (0-40), List Recall (0-10), and List Recognition (0-20) sections from the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) are used to assess Verbal memory.The range of scores for each section are in parentheses. Higher scores reflect better verbal memory. Scores are averaged for a total Verbal memory score, then converted to Z-score.
Z-scores are used when neurocognitive test scores use different measurement scales, e.g., time to completion and number correct. This allows to report performance in a straightforward manner, with low and high scores reflecting poor and good performance consistently across different types of tests, and to provide interpretation of a person's performance in comparison to a group. For interpretive purposes, a z-score has a mean of 0 and a standard deviation of 1. This means that an individual who has a z-score of 1.5 is performing one and a half standard deviations above the group to which he/she is compared.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Memory Score Change</measure>
    <time_frame>Baseline, 3 months, 6 months</time_frame>
    <description>Visual memory will be assessed using Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). RBANS figure recall requires the participant to remember a recent figure and redraw it from memory. The range of possible scores is 0-20. Scores are averaged, and then converted to z score.
Z-scores are used when neurocognitive test scores use different measurement scales, e.g., time to completion and number correct. This allows to report performance in a straightforward manner, with low and high scores reflecting poor and good performance consistently across different types of tests, and to provide interpretation of a person's performance in comparison to a group. For interpretive purposes, a z-score has a mean of 0 and a standard deviation of 1. This means that an individual who has a z-score of 1.5 is performing one and a half standard deviations above the group to which he/she is compared.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Processing Speed/Attention Score</measure>
    <time_frame>Baseline, 3 months, 6 months</time_frame>
    <description>RBANS coding (0-89) Color Trails 1 (timed test, 1-5 minutes) measures attention. The length of time to complete each part is recorded; lower raw scores reflect better processing speed and attention. Lower raw scores reflect better processing speed and attention. Scores are averaged for a total score, then converted to Z scores.
Z-scores are used when neurocognitive test scores use different measurement scales, e.g., time to completion and number correct. This allows to report performance in a straightforward manner, with low and high scores reflecting poor and good performance consistently across different types of tests, and to provide interpretation of a person's performance in comparison to a group. For interpretive purposes, a z-score has a mean of 0 and a standard deviation of 1. This means that an individual who has a z-score of 1.5 is performing one and a half standard deviations above the group to which he/she is compared.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Working Memory Score</measure>
    <time_frame>Baseline, 3 months, 6 months</time_frame>
    <description>Digit Span Forward (0-16), Digit Span Backwards (0-16), Digit Span Sequencing (0-16) and Letter Number Sequencing (0-48) sections from the Wechsler Adult Intelligence Scale - Fourth Edition are used to assess Working Memory. The range of possible scores for each section are in parentheses. The Digit Span subtest require the repetition of verbally presented series of numbers that increase in length; trials include the repeating of numbers in forward, backward, and numerical order. The Letter-Number sequencing test requires the repeating strings of letters and numbers in numerical and then in alphabetical order. Color Trails Test (CTT) Part 2, participants rapidly connect numbered circles in sequence while alternating between pink and yellow circles. Higher scores reflect better outcome. Scores reflect number correct and are averaged for total correct Working Memory score; are then converted to Z-score.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Reaction Time</measure>
    <time_frame>Baseline, 3 months, 6 months</time_frame>
    <description>Scores are automatically calculated via the scoring software embedded within the CalCap and are standardized based on age and education level norms. Normative data are stratified by both age (20-34, 35-44, 45+) and education (&lt; 16 years, 16 years, &gt; 16 years). Lower scores reflect slower reaction time and higher scores reflect faster reaction time. Scores are automatically converted to age/education based standard scores and are reported as a T-score.
T-scores (as Z-scores) are used when neurocognitive test scores use different measurement scales, e.g., time to completion and number correct. This allows to report performance in a straightforward manner, with low and high scores reflecting poor and good performance consistently across different types of tests, and to provide interpretation of a person's performance in comparison to a group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional Capacity</measure>
    <time_frame>Baseline, 3 months, 6 months</time_frame>
    <description>Functional capacity will be assessed by six-minute walk across all 3 arms of the study.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Peak V02</measure>
    <time_frame>Baseline and 3 months</time_frame>
    <description>To evaluate change in cardio-respiratory fitness Peak V02 was assessed at baseline and 3 months using a motorized treadmill test across 3 arms of the study</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">69</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Exercise and Cognitive retraining</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Aerobic exercise; Computerized cognitive retraining program; Heart failure education; Home visits; telephone follow-up.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exercise only</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each participant will be provided with an individualized target heart rate (THR)zone based on treadmill results. Under the supervision of a research nurse, participants will begin the walking sessions at 60% of THR and increase to 70% by week 5. Participants will walk a minimum of 5 times per week for a duration of 30 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stretching and Flexibility</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Stretching and flexibility movements; heart failure education; home visits; telephone follow-up.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise and Cognitive retraining</intervention_name>
    <description>Walking 5 times per week at moderate intensity; cognitive retraining one-hour 2 times per week.</description>
    <arm_group_label>Exercise and Cognitive retraining</arm_group_label>
    <other_name>Aerobic exercise; walking and computerized cognitive retraining program</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise Only</intervention_name>
    <arm_group_label>Exercise only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Stretching and Flexibility</intervention_name>
    <arm_group_label>Stretching and Flexibility</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        men and women between the ages of 40 and 75; English speaking; live independently within a
        60 mile radius of Atlanta; meet education corrected cut-offs on the MMSE indicating
        cognitive impairment (score of 20 for 8-9 yrs of schooling; 22 for 10-12 yrs of schooling;
        23 for &gt;12 yrs) have a computer with internet connection; documented medical diagnosis of
        NYHA class II or III systolic. Left ventricular ejection fraction (LVEF) â‰¥ 10% that is
        documented within the last year by echocardiogram, cardiac catheterization ventriculography
        or radionuclide ventriculography; Receiving medication therapy for HF according to American
        College of Cardiology (ACC) American Heart recommendation guidelines for at least 8 weeks
        prior to study enrollment.

        -

        Exclusion Criteria:

        NYHA class I or IV; change in HF therapy within 8 weeks; worsening HF symptoms within last
        5 days; unstable angina; renal insufficiency (serum creatinine &gt; 3.o mg/dL); fixed rate
        pacemaker; uncontrolled hypertension; not involved in any structured exercise program or
        exercising 3 or more times per week for a minimum of 30 minutes and; not hospitalized
        within the last 30-days; not diagnosed with any neurological disorder that may interfere
        with cognitive function; Beck Depression Inventory II (BDI-II) score greater than 25; any
        disorder interfering with exercise participation.

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Emory University Heart Failure Clinics</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>May 28, 2014</study_first_submitted>
  <study_first_submitted_qc>May 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 30, 2014</study_first_posted>
  <results_first_submitted>April 9, 2019</results_first_submitted>
  <results_first_submitted_qc>July 24, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">August 14, 2019</results_first_posted>
  <last_update_submitted>July 24, 2019</last_update_submitted>
  <last_update_submitted_qc>July 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Emory University</investigator_affiliation>
    <investigator_full_name>Rebecca Gary</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Heart failure</keyword>
  <keyword>Exercise</keyword>
  <keyword>Cognitive training</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 3, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/66/NCT02151266/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Exercise and Cognitive Retraining</title>
          <description>Aerobic exercise; Computerized cognitive retraining program; Heart failure education; Home visits; telephone follow-up.
Exercise and Cognitive retraining: Walking 5 times per week at moderate intensity; cognitive retraining one-hour 2 times per week.</description>
        </group>
        <group group_id="P2">
          <title>Exercise Only</title>
          <description>Each participant will be provided with an individualized target heart rate (THR)zone based on treadmill results. Under the supervision of a research nurse, participants will begin the walking sessions at 60% of THR and increase to 70% by week 5. Participants will walk a minimum of 5 times per week for a duration of 30 minutes.
Exercise Only</description>
        </group>
        <group group_id="P3">
          <title>Stretching and Flexibility</title>
          <description>Stretching and flexibility movements; heart failure education; home visits; telephone follow-up.
Stretching and Flexibility</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="29"/>
                <participants group_id="P3" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="14"/>
                <participants group_id="P3" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Did NOT receive intervention</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Not able to exercise</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Exercise and Cognitive Retraining</title>
          <description>Aerobic exercise; Computerized cognitive retraining program; Heart failure education; Home visits; telephone follow-up.
Exercise and Cognitive retraining: Walking 5 times per week at moderate intensity; cognitive retraining one-hour 2 times per week.</description>
        </group>
        <group group_id="B2">
          <title>Exercise Only</title>
          <description>Each participant will be provided with an individualized target heart rate (THR)zone based on treadmill results. Under the supervision of a research nurse, participants will begin the walking sessions at 60% of THR and increase to 70% by week 5. Participants will walk a minimum of 5 times per week for a duration of 30 minutes.
Exercise Only</description>
        </group>
        <group group_id="B3">
          <title>Stretching and Flexibility</title>
          <description>Stretching and flexibility movements; heart failure education; home visits; telephone follow-up.
Stretching and Flexibility</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="19"/>
            <count group_id="B2" value="29"/>
            <count group_id="B3" value="21"/>
            <count group_id="B4" value="69"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59" spread="11"/>
                    <measurement group_id="B2" value="60" spread="10"/>
                    <measurement group_id="B3" value="63" spread="9"/>
                    <measurement group_id="B4" value="61" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="37"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Verbal Memory Score Change</title>
        <description>List Learning (0-40), List Recall (0-10), and List Recognition (0-20) sections from the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) are used to assess Verbal memory.The range of scores for each section are in parentheses. Higher scores reflect better verbal memory. Scores are averaged for a total Verbal memory score, then converted to Z-score.
Z-scores are used when neurocognitive test scores use different measurement scales, e.g., time to completion and number correct. This allows to report performance in a straightforward manner, with low and high scores reflecting poor and good performance consistently across different types of tests, and to provide interpretation of a person's performance in comparison to a group. For interpretive purposes, a z-score has a mean of 0 and a standard deviation of 1. This means that an individual who has a z-score of 1.5 is performing one and a half standard deviations above the group to which he/she is compared.</description>
        <time_frame>Baseline, 3 months, 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise and Cognitive Retraining</title>
            <description>Aerobic exercise; Computerized cognitive retraining program; Heart failure education; Home visits; telephone follow-up.
Exercise and Cognitive retraining: Walking 5 times per week at moderate intensity; cognitive retraining one-hour 2 times per week.</description>
          </group>
          <group group_id="O2">
            <title>Exercise Only</title>
            <description>Each participant will be provided with an individualized target heart rate (THR)zone based on treadmill results. Under the supervision of a research nurse, participants will begin the walking sessions at 60% of THR and increase to 70% by week 5. Participants will walk a minimum of 5 times per week for a duration of 30 minutes.
Exercise Only</description>
          </group>
          <group group_id="O3">
            <title>Stretching and Flexibility</title>
            <description>Stretching and flexibility movements; heart failure education; home visits; telephone follow-up.
Stretching and Flexibility</description>
          </group>
        </group_list>
        <measure>
          <title>Verbal Memory Score Change</title>
          <description>List Learning (0-40), List Recall (0-10), and List Recognition (0-20) sections from the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) are used to assess Verbal memory.The range of scores for each section are in parentheses. Higher scores reflect better verbal memory. Scores are averaged for a total Verbal memory score, then converted to Z-score.
Z-scores are used when neurocognitive test scores use different measurement scales, e.g., time to completion and number correct. This allows to report performance in a straightforward manner, with low and high scores reflecting poor and good performance consistently across different types of tests, and to provide interpretation of a person's performance in comparison to a group. For interpretive purposes, a z-score has a mean of 0 and a standard deviation of 1. This means that an individual who has a z-score of 1.5 is performing one and a half standard deviations above the group to which he/she is compared.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.08" spread="0.20"/>
                    <measurement group_id="O2" value="-0.08" spread="0.15"/>
                    <measurement group_id="O3" value="0.18" spread="0.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.47" spread="0.21"/>
                    <measurement group_id="O2" value="0.14" spread="0.18"/>
                    <measurement group_id="O3" value="0.37" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.20" spread="0.21"/>
                    <measurement group_id="O2" value="0.07" spread="0.19"/>
                    <measurement group_id="O3" value="0.25" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Functional Capacity</title>
        <description>Functional capacity will be assessed by six-minute walk across all 3 arms of the study.</description>
        <time_frame>Baseline, 3 months, 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise and Cognitive Retraining</title>
            <description>Aerobic exercise; Computerized cognitive retraining program; Heart failure education; Home visits; telephone follow-up.
Exercise and Cognitive retraining: Walking 5 times per week at moderate intensity; cognitive retraining one-hour 2 times per week.</description>
          </group>
          <group group_id="O2">
            <title>Exercise Only</title>
            <description>Each participant will be provided with an individualized target heart rate (THR)zone based on treadmill results. Under the supervision of a research nurse, participants will begin the walking sessions at 60% of THR and increase to 70% by week 5. Participants will walk a minimum of 5 times per week for a duration of 30 minutes.
Exercise Only</description>
          </group>
          <group group_id="O3">
            <title>Stretching and Flexibility</title>
            <description>Stretching and flexibility movements; heart failure education; home visits; telephone follow-up.
Stretching and Flexibility</description>
          </group>
        </group_list>
        <measure>
          <title>Functional Capacity</title>
          <description>Functional capacity will be assessed by six-minute walk across all 3 arms of the study.</description>
          <units>meters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="324.1" spread="19.2"/>
                    <measurement group_id="O2" value="355.1" spread="15.9"/>
                    <measurement group_id="O3" value="337.6" spread="18.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="311.1" spread="20.0"/>
                    <measurement group_id="O2" value="358.8" spread="16.9"/>
                    <measurement group_id="O3" value="388.4" spread="20.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="321.2" spread="20.2"/>
                    <measurement group_id="O2" value="374.9" spread="18.7"/>
                    <measurement group_id="O3" value="374.9" spread="20.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Peak V02</title>
        <description>To evaluate change in cardio-respiratory fitness Peak V02 was assessed at baseline and 3 months using a motorized treadmill test across 3 arms of the study</description>
        <time_frame>Baseline and 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise and Cognitive Retraining</title>
            <description>Aerobic exercise; Computerized cognitive retraining program; Heart failure education; Home visits; telephone follow-up.
Exercise and Cognitive retraining: Walking 5 times per week at moderate intensity; cognitive retraining one-hour 2 times per week.</description>
          </group>
          <group group_id="O2">
            <title>Exercise Only</title>
            <description>Each participant will be provided with an individualized target heart rate (THR)zone based on treadmill results. Under the supervision of a research nurse, participants will begin the walking sessions at 60% of THR and increase to 70% by week 5. Participants will walk a minimum of 5 times per week for a duration of 30 minutes.
Exercise Only</description>
          </group>
          <group group_id="O3">
            <title>Stretching and Flexibility</title>
            <description>Stretching and flexibility movements; heart failure education; home visits; telephone follow-up.
Stretching and Flexibility</description>
          </group>
        </group_list>
        <measure>
          <title>Peak V02</title>
          <description>To evaluate change in cardio-respiratory fitness Peak V02 was assessed at baseline and 3 months using a motorized treadmill test across 3 arms of the study</description>
          <units>mL/kg/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.9" spread="1.3"/>
                    <measurement group_id="O2" value="16.2" spread="1.0"/>
                    <measurement group_id="O3" value="19.3" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.3" spread="1.3"/>
                    <measurement group_id="O2" value="16.0" spread="1.0"/>
                    <measurement group_id="O3" value="19.3" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Visual Memory Score Change</title>
        <description>Visual memory will be assessed using Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). RBANS figure recall requires the participant to remember a recent figure and redraw it from memory. The range of possible scores is 0-20. Scores are averaged, and then converted to z score.
Z-scores are used when neurocognitive test scores use different measurement scales, e.g., time to completion and number correct. This allows to report performance in a straightforward manner, with low and high scores reflecting poor and good performance consistently across different types of tests, and to provide interpretation of a person's performance in comparison to a group. For interpretive purposes, a z-score has a mean of 0 and a standard deviation of 1. This means that an individual who has a z-score of 1.5 is performing one and a half standard deviations above the group to which he/she is compared.</description>
        <time_frame>Baseline, 3 months, 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise and Cognitive Retraining</title>
            <description>Aerobic exercise; Computerized cognitive retraining program; Heart failure education; Home visits; telephone follow-up.
Exercise and Cognitive retraining: Walking 5 times per week at moderate intensity; cognitive retraining one-hour 2 times per week.</description>
          </group>
          <group group_id="O2">
            <title>Exercise Only</title>
            <description>Each participant will be provided with an individualized target heart rate (THR)zone based on treadmill results. Under the supervision of a research nurse, participants will begin the walking sessions at 60% of THR and increase to 70% by week 5. Participants will walk a minimum of 5 times per week for a duration of 30 minutes.
Exercise Only</description>
          </group>
          <group group_id="O3">
            <title>Stretching and Flexibility</title>
            <description>Stretching and flexibility movements; heart failure education; home visits; telephone follow-up.
Stretching and Flexibility</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Memory Score Change</title>
          <description>Visual memory will be assessed using Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). RBANS figure recall requires the participant to remember a recent figure and redraw it from memory. The range of possible scores is 0-20. Scores are averaged, and then converted to z score.
Z-scores are used when neurocognitive test scores use different measurement scales, e.g., time to completion and number correct. This allows to report performance in a straightforward manner, with low and high scores reflecting poor and good performance consistently across different types of tests, and to provide interpretation of a person's performance in comparison to a group. For interpretive purposes, a z-score has a mean of 0 and a standard deviation of 1. This means that an individual who has a z-score of 1.5 is performing one and a half standard deviations above the group to which he/she is compared.</description>
          <units>z scores</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.09" spread="0.23"/>
                    <measurement group_id="O2" value="-0.17" spread="0.18"/>
                    <measurement group_id="O3" value="0.29" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.21" spread="0.24"/>
                    <measurement group_id="O2" value="0.08" spread="0.21"/>
                    <measurement group_id="O3" value="0.18" spread="0.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.90" spread="0.25"/>
                    <measurement group_id="O2" value="-0.14" spread="0.23"/>
                    <measurement group_id="O3" value="0.32" spread="0.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Processing Speed/Attention Score</title>
        <description>RBANS coding (0-89) Color Trails 1 (timed test, 1-5 minutes) measures attention. The length of time to complete each part is recorded; lower raw scores reflect better processing speed and attention. Lower raw scores reflect better processing speed and attention. Scores are averaged for a total score, then converted to Z scores.
Z-scores are used when neurocognitive test scores use different measurement scales, e.g., time to completion and number correct. This allows to report performance in a straightforward manner, with low and high scores reflecting poor and good performance consistently across different types of tests, and to provide interpretation of a person's performance in comparison to a group. For interpretive purposes, a z-score has a mean of 0 and a standard deviation of 1. This means that an individual who has a z-score of 1.5 is performing one and a half standard deviations above the group to which he/she is compared.</description>
        <time_frame>Baseline, 3 months, 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise and Cognitive Retraining</title>
            <description>Aerobic exercise; Computerized cognitive retraining program; Heart failure education; Home visits; telephone follow-up.
Exercise and Cognitive retraining: Walking 5 times per week at moderate intensity; cognitive retraining one-hour 2 times per week.</description>
          </group>
          <group group_id="O2">
            <title>Exercise Only</title>
            <description>Each participant will be provided with an individualized target heart rate (THR)zone based on treadmill results. Under the supervision of a research nurse, participants will begin the walking sessions at 60% of THR and increase to 70% by week 5. Participants will walk a minimum of 5 times per week for a duration of 30 minutes.
Exercise Only</description>
          </group>
          <group group_id="O3">
            <title>Stretching and Flexibility</title>
            <description>Stretching and flexibility movements; heart failure education; home visits; telephone follow-up.
Stretching and Flexibility</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Processing Speed/Attention Score</title>
          <description>RBANS coding (0-89) Color Trails 1 (timed test, 1-5 minutes) measures attention. The length of time to complete each part is recorded; lower raw scores reflect better processing speed and attention. Lower raw scores reflect better processing speed and attention. Scores are averaged for a total score, then converted to Z scores.
Z-scores are used when neurocognitive test scores use different measurement scales, e.g., time to completion and number correct. This allows to report performance in a straightforward manner, with low and high scores reflecting poor and good performance consistently across different types of tests, and to provide interpretation of a person's performance in comparison to a group. For interpretive purposes, a z-score has a mean of 0 and a standard deviation of 1. This means that an individual who has a z-score of 1.5 is performing one and a half standard deviations above the group to which he/she is compared.</description>
          <units>z scores</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.09" spread="0.11"/>
                    <measurement group_id="O2" value="-0.02" spread="0.10"/>
                    <measurement group_id="O3" value="0.12" spread="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.09" spread="0.12"/>
                    <measurement group_id="O2" value="0.13" spread="0.11"/>
                    <measurement group_id="O3" value="-0.01" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.20" spread="0.13"/>
                    <measurement group_id="O2" value="-0.02" spread="0.12"/>
                    <measurement group_id="O3" value="-0.18" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Working Memory Score</title>
        <description>Digit Span Forward (0-16), Digit Span Backwards (0-16), Digit Span Sequencing (0-16) and Letter Number Sequencing (0-48) sections from the Wechsler Adult Intelligence Scale - Fourth Edition are used to assess Working Memory. The range of possible scores for each section are in parentheses. The Digit Span subtest require the repetition of verbally presented series of numbers that increase in length; trials include the repeating of numbers in forward, backward, and numerical order. The Letter-Number sequencing test requires the repeating strings of letters and numbers in numerical and then in alphabetical order. Color Trails Test (CTT) Part 2, participants rapidly connect numbered circles in sequence while alternating between pink and yellow circles. Higher scores reflect better outcome. Scores reflect number correct and are averaged for total correct Working Memory score; are then converted to Z-score.</description>
        <time_frame>Baseline, 3 months, 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise and Cognitive Retraining</title>
            <description>Aerobic exercise; Computerized cognitive retraining program; Heart failure education; Home visits; telephone follow-up.
Exercise and Cognitive retraining: Walking 5 times per week at moderate intensity; cognitive retraining one-hour 2 times per week.</description>
          </group>
          <group group_id="O2">
            <title>Exercise Only</title>
            <description>Each participant will be provided with an individualized target heart rate (THR)zone based on treadmill results. Under the supervision of a research nurse, participants will begin the walking sessions at 60% of THR and increase to 70% by week 5. Participants will walk a minimum of 5 times per week for a duration of 30 minutes.
Exercise Only</description>
          </group>
          <group group_id="O3">
            <title>Stretching and Flexibility</title>
            <description>Stretching and flexibility movements; heart failure education; home visits; telephone follow-up.
Stretching and Flexibility</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Working Memory Score</title>
          <description>Digit Span Forward (0-16), Digit Span Backwards (0-16), Digit Span Sequencing (0-16) and Letter Number Sequencing (0-48) sections from the Wechsler Adult Intelligence Scale - Fourth Edition are used to assess Working Memory. The range of possible scores for each section are in parentheses. The Digit Span subtest require the repetition of verbally presented series of numbers that increase in length; trials include the repeating of numbers in forward, backward, and numerical order. The Letter-Number sequencing test requires the repeating strings of letters and numbers in numerical and then in alphabetical order. Color Trails Test (CTT) Part 2, participants rapidly connect numbered circles in sequence while alternating between pink and yellow circles. Higher scores reflect better outcome. Scores reflect number correct and are averaged for total correct Working Memory score; are then converted to Z-score.</description>
          <units>z scores</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.04" spread="0.12"/>
                    <measurement group_id="O2" value="0.09" spread="0.10"/>
                    <measurement group_id="O3" value="-0.07" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.03" spread="0.13"/>
                    <measurement group_id="O2" value="0.12" spread="0.11"/>
                    <measurement group_id="O3" value="-0.16" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.15" spread="0.13"/>
                    <measurement group_id="O2" value="0.10" spread="0.12"/>
                    <measurement group_id="O3" value="-0.03" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Reaction Time</title>
        <description>Scores are automatically calculated via the scoring software embedded within the CalCap and are standardized based on age and education level norms. Normative data are stratified by both age (20-34, 35-44, 45+) and education (&lt; 16 years, 16 years, &gt; 16 years). Lower scores reflect slower reaction time and higher scores reflect faster reaction time. Scores are automatically converted to age/education based standard scores and are reported as a T-score.
T-scores (as Z-scores) are used when neurocognitive test scores use different measurement scales, e.g., time to completion and number correct. This allows to report performance in a straightforward manner, with low and high scores reflecting poor and good performance consistently across different types of tests, and to provide interpretation of a person's performance in comparison to a group.</description>
        <time_frame>Baseline, 3 months, 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise and Cognitive Retraining</title>
            <description>Aerobic exercise; Computerized cognitive retraining program; Heart failure education; Home visits; telephone follow-up.
Exercise and Cognitive retraining: Walking 5 times per week at moderate intensity; cognitive retraining one-hour 2 times per week.</description>
          </group>
          <group group_id="O2">
            <title>Exercise Only</title>
            <description>Each participant will be provided with an individualized target heart rate (THR)zone based on treadmill results. Under the supervision of a research nurse, participants will begin the walking sessions at 60% of THR and increase to 70% by week 5. Participants will walk a minimum of 5 times per week for a duration of 30 minutes.
Exercise Only</description>
          </group>
          <group group_id="O3">
            <title>Stretching and Flexibility</title>
            <description>Stretching and flexibility movements; heart failure education; home visits; telephone follow-up.
Stretching and Flexibility</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Reaction Time</title>
          <description>Scores are automatically calculated via the scoring software embedded within the CalCap and are standardized based on age and education level norms. Normative data are stratified by both age (20-34, 35-44, 45+) and education (&lt; 16 years, 16 years, &gt; 16 years). Lower scores reflect slower reaction time and higher scores reflect faster reaction time. Scores are automatically converted to age/education based standard scores and are reported as a T-score.
T-scores (as Z-scores) are used when neurocognitive test scores use different measurement scales, e.g., time to completion and number correct. This allows to report performance in a straightforward manner, with low and high scores reflecting poor and good performance consistently across different types of tests, and to provide interpretation of a person's performance in comparison to a group.</description>
          <units>t scores</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="0.22"/>
                    <measurement group_id="O2" value="0.11" spread="0.18"/>
                    <measurement group_id="O3" value="0.29" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.05" spread="0.25"/>
                    <measurement group_id="O2" value="0.07" spread="0.21"/>
                    <measurement group_id="O3" value="0.18" spread="0.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.24"/>
                    <measurement group_id="O2" value="-0.13" spread="0.23"/>
                    <measurement group_id="O3" value="0.30" spread="0.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Exercise and Cognitive Retraining</title>
          <description>Aerobic exercise; Computerized cognitive retraining program; Heart failure education; Home visits; telephone follow-up.
Exercise and Cognitive retraining: Walking 5 times per week at moderate intensity; cognitive retraining one-hour 2 times per week.</description>
        </group>
        <group group_id="E2">
          <title>Exercise Only</title>
          <description>Each participant will be provided with an individualized target heart rate (THR)zone based on treadmill results. Under the supervision of a research nurse, participants will begin the walking sessions at 60% of THR and increase to 70% by week 5. Participants will walk a minimum of 5 times per week for a duration of 30 minutes.
Exercise Only</description>
        </group>
        <group group_id="E3">
          <title>Stretching and Flexibility</title>
          <description>Stretching and flexibility movements; heart failure education; home visits; telephone follow-up.
Stretching and Flexibility</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Gary</name_or_title>
      <organization>Emory University</organization>
      <phone>404-727-8360</phone>
      <email>ragary@emory.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

